BioChaperone insulin lispro

DRUG5 trials

Sponsors

Adocia

Conditions

Diabetes Mellitus Type 1Type 1 Diabetes MellitusType 2 Diabetes Mellitus

Phase 1

A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 Diabetes

CompletedNCT02029924

AdociaDiabetes Mellitus Type 1

Start: 2013-12-31End: 2014-08-31Updated: 2017-06-01

Blood Glucose Control With BioChaperone Insulin Lispro Compared to Insulin Lispro (Humalog®) After Ingestion of a Standardized Meal

CompletedNCT02344992

AdociaDiabetes Mellitus Type 1

Start: 2015-01-31End: 2015-06-30Updated: 2017-06-01

To Investigate the Efficacy and Safety of Individualized Doses of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 1 Diabetes Mellitus

CompletedNCT02528396

AdociaType 1 Diabetes Mellitus

Start: 2015-08-31End: 2015-12-31Updated: 2016-03-16

A Trial Investigating the Continuous Subcutaneous Insulin Infusion of a Liquid Formulation of BioChaperone Insulin Lispro in Comparison to Humalog®

CompletedNCT02562313

AdociaType 1 Diabetes Mellitus

Start: 2015-09-30End: 2016-11-30Updated: 2016-11-22

A Trial to Investigate the Efficacy, Pharmacokinetics, Safety and Tolerability of BioChaperone Insulin Lispro in Comparison to Humalog® U-100 in Patients With Type 2 Diabetes Mellitus

CompletedNCT02562326

AdociaType 2 Diabetes Mellitus

Start: 2015-09-30End: 2016-01-31Updated: 2016-04-29